×
Sign In
Jubil Logo Accessibility Menu Arabic Search Menu
 
نهاد محمود ايوب
• قسم الصيدلة السريرية - عضو هيئة تدريس

  • الدكـتوراة في صيدله من جامعة لويزيانا في مونروا, 2012
  • ماجستير في صيدله من جامعة العلوم والتكنولوجيا الاردنيه, 2006
  • بكالوريوس في صيدله من جامعة العلوم والتكنولوجيا الاردنيه, 2004

    Publications
  • Akl MR, Nagpal P, Ayoub NM, Tai B, Prabhu SA, Capac CM, Gliksman, Goy A, Suh KS. , "Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies," Oncotarget, vol. , no. , pp. 0-0, 2016
  • Akl MR, Nagpal P, Ayoub NM, Prabhu SA, Gliksman M, Tai B, Hatipoglu A, Goy A, Suh KS , "Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine," Oncotarget, vol. 6, no. 30, pp. 28693-715, 2015
  • Ayoub NM, Kaddoumi A , "Obesity and Breast Cancer: Molecular and Epidemiological Evidence," Journal of Cancer Research Updates, vol. 4, no. , pp. 30-42, 2015
  • Akl MR, Ayoub NM, Ebrahim HY, Mohyelsin MM, Orabi KY, Fouah AI, El Sayed KA. , "Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling," Marine Drugs, vol. 13, no. , pp. 288-311, 2015
  • Al-Azzam S, Alzuobi KH, Ayoub NM et al. , "AN AUDIT ON PUBLIC AWARENESS OF DEPRESSION SYMPTOMS IN JORDAN," International Journal of Occupational Medicine and Environmental Health, vol. 26, no. 4, pp. 545-554, 2013
  • Ayoub NM, Lucas C, Kaddoumi A. , "Genomics and Pharmacogenomics of Breast Cancer: Current Knowledge and Trends," Asian Pacific J Cancer Prev, vol. 12, no. , pp. 1127-1140, 2011
  • AlZoubi K, Ayoub N, Al-Sakaji S et al. , "AWARENESS OF BACTERIAL RESISTANCE AMONG PHYSICIANS, PHARMACISTS AND NURSES," International Journal of Occupational Medicine and Environmental Health, vol. 22, no. 4, pp. 363-372, 2009
  • Sallam AA, Ayoub NM, Foudah AI, Gissedanner CR, Meyer SA, El Sayed KA. , "Indole Diterpene Alkaloids as Novel Inhibitors of the Wnt/?-catenin Pathway in Breast Cancer Cells," Eur J Med Chem., vol. 70, no. , pp. 0-0, 2013
  • Akl MR, Ayoub NM, Mohyeldin MM, Busnena BA, Foudah AI, Liu YY, Sayed KA. , "Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.," PLoS One, vol. 9, no. 5, pp. 97622-0, 2014
  • "(-)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models", Cancers
  • "(?)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo", Nutrients
  • "A Survey of Knowledge and Barriers of Healthcare Professionals toward Opioid Analgesics in Cancer Pain Management", International Journal of Clinical Practice
  • "A baseline survey of community pharmacies? workforce, premises, services and satisfaction with medical practitioners in Jordan", International Journal of Clinical Practice
  • "Analysis of circulating adipokines in patients newly diagnosed with solid cancer: Associations with measures of adiposity and tumor characteristics ", Oncology Letters
  • "Assessment of satisfaction of attendees of healthcare centers in Jordan with community pharmacy services of pharmacies they usually use", PLOS ONE
  • "Association of DNA Repair Gene Polymorphisms with Colorectal Cancer Risk and Treatment Outcomes", Experimental and Molecular Pathology
  • "Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor", Medical oncology
  • "Community pharmacists? routine provision of drug-related problem-reduction services", PLOS ONE
  • "Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels", Investigational New Drugs
  • "Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents", OncoTargets and Therapy
  • "Discovery of a Nanomolar Inhibitor of the Human Glyoxalase-I Enzyme Using Structure-Based Poly-pharmacophore Modelling and Molecular Docking", Journal of Computer-Aided Molecular Design
  • "Editorial: Novel Combination Therapies for the Treatment of Solid Cancers", Frontiers in oncology
  • "Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer", Breast Cancer: Basic and Clinical Research
  • "Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset", PLoS ONE
  • "Expression of Insulin Receptor and c-MET Is Associated with Clinicopathologic Characteristics and Molecular Subtypes in Premenopausal Breast Cancer Patients", Applied Sciences
  • "Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications.", International Journal of Nanomedicine
  • "HPLC with Fluorescence and Photodiode Array Detection for Quantifying Capmatinib in Biological Samples: Application to In Vivo and In Vitro Studies", Molecules
  • "ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer", Clinical Breast Cancer
  • "Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches", Breast Cancer: Targets and Therapy
  • "Knowledge of and willingness for dispensing oral anticancer drug therapy among community pharmacists: a cross-sectional study from Jordan", Journal of Pharmaceutical Health Services Research
  • "Knowledge, Attitudes, and Practice Regarding Research Ethics Committees Among Health Care Faculty at Two Public Universities in Jordan.", Journal of Empirical Research on Human Research Ethics
  • "Management of Sickle Cell Disease Pain among Adolescent and Pediatric Patients", Brain Sciences
  • "Organophosphate pesticide exposure prenatally influence on pregnancy outcomes", THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
  • "Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: Evidence from preclinical and clinical studies", Medical oncology
  • "ProBDNF is a Novel Mediator of the Interaction Between MDA-MB- 231 Breast Cancer Cells and Brain Microvascular Endothelial Cells", Current Molecular Medicine
  • "Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study", Breast Cancer: Targets and Therapy
  • "Protein calorie malnutrition, nutritional intervention and personalized cancer care", Oncotarget
  • "Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor", Pharmacological Research
  • "Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches", Frontiers in pharmacology
  • "The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset", Breast Journal
  • "The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic", marine drugs
  • "The impact of tumor-infiltrating lymphocytes on tumor features and pathological characteristics in breast cancer patients: the role of cytotoxic T lymphocytes and regulatory T cells", European Review for Medical and Pharmacological Sciences
  • "The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment", European Journal of Pharmacology
  • Assistant Dean, Assistant Dean, Sep 2020 - Sep 2021
  • Assistant Dean, Assistant Dean, Sep 2019 - Sep 2020
  • Faculty Member, Department of Clinical Pharmacy, Apr 2013 - Present
  • Full-time Lecturer, Department of Clinical Pharmacy, Jun 2008 - Dec 2008
  • ADVANCED THERAPEUTICS
  • CLINICAL PHARMACOLOGY
  • CLINICAL PHARMACY AND THERAPEUTICS (1)
  • CLINICAL SEMINAR (1 ) (FOR PHD STUDENTS)
  • CLINICAL SEMINAR (FOR PHARM.D STUDENTS)
  • CLINICAL TRAINING : PHARMACEUTICAL RESEARCH (FOR PHARM.D STUDENTS)
  • CLINICAL TRAINING : PSYCHIATRY (FOR PHARM.D STUDENTS)
  • CLINICAL TRAINING: NUTRITIONAL SUPPORT (FOR PHARM.D STUDENTS)
  • CLINICAL TRAINING: ONCOLOGY (FOR PHARM D STUDENTS)
  • CLINICAL TRAINING: PEDIATRIC ONCOLOGY
  • COMMUNITY PHARMACY (FOR PHARM.D STUDENTS)
  • Clinical Cases 3 (for Pharm D) students)
  • Clinical Seminar (for Pharm D students)
  • Clinical Training: Clinical Pharmaceutical Research
  • Early Practice Experience (for Pharm D students)
  • INTRODUCTION TO THERAPEUTICS (FOR PHARMD STUDENTS)
  • MOLECULAR AND CELLULAR BIOLOGY
  • PHARMACOLOGY (1)
  • PHARMACOLOGY 1
  • PHARMACOLOGY 2
  • Pharmacology 1(for Pharm D students)
  • SCIENTIFIC WRITING AND RESEARCH ETHICS
  • SELECTED TOPICS ( 1)
  • SELECTED TOPICS ( 2)
  • SEMINAR
  • THERAPEUTICS
  • THERAPEUTICS ( 2)
  • THERAPEUTICS-COMPREHENSIVE (FOR PHARM.D STUDENTS)
  • THERAPEUTICS-IMMUNOLOGY, HEMATOLOGY AND ONCOLOGY (FOR PHARM.D STUDENTS)
  • THERAPEUTICS-IMMUNOLOGY, HEMATOLOGY AND ONCOLOGY (FOR PHARM.D STUDENTS)
  • TOXICOLOGY
  • Therapeutics- Immunology, Hematology and Oncology (for Pharm D students) students)
    Editorial Boards
  • BMC Women's Health, 2017 -2020
    Professional Memberships
  • AACR, , 2017